Japan Personalized Medicine Market Size, Share, and COVID-19 Impact Analysis, By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, and Personalized Nutrition & Wellness), By End Use (Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others), and Japan Personalized Medicine Market Insights, Industry Trend, Forecasts to 2035

Japan Personalized Medicine Market Size Insights Forecasts to 2035

• The Japan Personalized Medicine Market Size Was Estimated at USD 26687.1 million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 9.88 % from 2025 to 2035
• The Japan Personalized Medicine Market Size is Expected to Reach USD 75253.6 million by 2035

According to a Research Report Published by Spherical Insights & Consulting, the Japan Personalized Medicine Market Size is anticipated to reach USD 75253.6 million by 2035, growing at a CAGR of 9.88 % from 2025 to 2035. The personalized medicine market in Japan is driven by various factors, including rising demand for targeted therapies, rising prevalence of chronic diseases, technological advancements in genomics, and growing investment in research and development.

Market Overview

Personalized medicine, also referred to as precision medicine. Personalized medicine is a medical method that customizes preventative and treatment plans based on a person's environment, lifestyle, and genetic composition. Personalized medicine, in contrast to the traditional "one-size-fits-all" approach, enables more targeted and effective healthcare by determining which therapies are most likely to benefit specific patients. It plays an important role in enhancing therapeutic efficacy, reducing side effects, and promoting preventative care. The personalized medicine market includes products such as personalized medicine diagnostics, personalized medicine therapeutics, personalized medical care, and personalized nutrition & wellness. Japan is one of the aging population country and the aging population is more susceptible to chronic diseases like cancer. A report from the Japanese Ministry of Health, Labour and Welfare indicates that cancer is the leading cause of death in Japan, accounting for approximately 27% of all deaths in 2021, which further created the demand for targeted treatments is one of the major contributors to this market. Japanese hospitals are using DNA-based diagnostics to tailor treatments, especially for cancer, leading to more precise care and better patient outcomes is a key trend in this market.

Report Coverage

This research report categorizes the market for the Japan personalized medicine market based on various segments and regions, and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan personalized medicine market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan personalized medicine market.

Driving Factors

One of the primary drivers of the market is the increased occurrence of genetic abnormalities and chronic illnesses among the Japanese population. The need for individualized treatment alternatives is increasing as the population ages, prompting healthcare practitioners to embrace personalized medicine practices. Strong government support for precision medicine is highlighted in Japan's Healthcare Policy 2025, which additionally supports the integration of genetic data and advances genome sequencing for individualized therapies. Additionally, technological advancements play an important role in market expansion.

Restraining Factors

The personalized medicines are expensive compared to traditional medicines, which limit access for several patients and create pressure on healthcare budgets. Additionally, a lack of clear regulations leads to slow approval and adoption of personalized medicine technologies.

Market Segmentation

The Japan personalized medicine market share is classified into product and end use.   

• The personalized nutrition & wellness segment held a dominant market share in 2024 and is expected to grow at a rapid CAGR during the forecast period.    

The Japan personalized medicine market is segmented by product into personalized medicine diagnostics, personalized medicine therapeutics, personalized medical care, and personalized nutrition & wellness. Among these, personalized nutrition & wellness held a dominant market share in 2024 and is expected to grow at a rapid CAGR during the forecast period. This is due to rising consumer interest in preventive health and lifestyle optimization. Additionally, rising demand for tailored dietary supplements and fitness plans boosted the segmental growth.

• The hospitals segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.   

The Japan personalized medicine market is segmented by end use into hospitals, diagnostic centers, research & academic institutes, and others. Among these, the hospitals segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to hospitals are primary centers for implementing personalized treatment plans in oncology, cardiology, and chronic disease management.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan personalized medicine market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Fujifilm
• Takeda Pharmaceutical
• Eisai
• Astellas Pharma
• Mitsubishi Tanabe Pharma
• Otsuka Pharmaceutical
• Daiichi Sankyo
• Ono Pharmaceutical
• Others

Recent Developments

• In July 2024, SoftBank Group Corp. and U.S.-based Tempus AI, Inc. launched a joint venture, SB TEMPUS Corp., to deliver AI-driven precision medicine services in Japan

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan personalized medicine market based on the below-mentioned segments:

Japan Personalized Medicine Market, By Product

• Personalized Medicine Diagnostics
• Personalized Medicine Therapeutics
• Personalized Medical Care
• Personalized Nutrition & Wellness

Japan Personalized Medicine Market, By End Use

• Hospitals
• Diagnostic Centers
• Research & Academic Institutes
• Others